Sparfloxacin versus clarithromycin in the treatment of community-acquired pneumonia (Q64133453)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10090428%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10090428%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

author name string

J Unowsky

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10090428%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

G H Talbot

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10090428%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

H Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10090428%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

L Townsend

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10090428%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

publication date

January 1999

0 references

number of pages

15

1 reference

inferred from page(s)

published in

Clinical Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10090428%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10090428%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10090428%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

page(s)

103-117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10090428%20AND%20SRC:MED&resulttype=core&format=json

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

11 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988271-5

7 January 2021

Community-acquired pneumonia: an update.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988271-5

7 January 2021

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988271-5

7 January 2021

Influence of age on symptoms at presentation in patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988271-5

7 January 2021

Prospective study of epidemiology and prognostic factors in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988271-5

7 January 2021

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988271-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988271-5

1 reference

7 January 2021

A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988271-5

7 January 2021

Safety profile of sparfloxacin in the treatment of respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988271-5

7 January 2021

Comparative efficacy of sparfloxacin in comparison with amoxycillin plus ofloxacin in the treatment of community-acquired pneumonia. French Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988271-5

7 January 2021

Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988271-5

7 January 2021

Etiology and therapy of community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988271-5

7 January 2021

Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988271-5

7 January 2021

Switch therapy in community-acquried pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988271-5

7 January 2021

10.1016/S0149-2918(00)88271-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10090428%20AND%20SRC:MED&resulttype=core&format=json

11 May 2020

1 reference